Skip to main content
Clinical Trials/NCT00916071
NCT00916071
Completed
Not Applicable

Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders

Massachusetts General Hospital0 sites64 target enrollmentOctober 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bulimia Nervosa
Sponsor
Massachusetts General Hospital
Enrollment
64
Primary Endpoint
We will identify the lifetime rate of mental health conditions using structured clinical interviews in subjects with a lifetime history of eating disorders and compare the rate of these conditions to that of non-ED control subjects.
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

To understand whether a relationship exists between eating disorders and ADHD, we seek to clarify the prevalence of ADHD in individuals with eating disorders. To this end, we will estimate the prevalence of ADHD, and other neuropsychiatric disorders, in outpatients with history of an eating disorder diagnosis. Secondarily, we will identify patterns of cognitive deficits in outpatients with history of an eating disorder diagnosis. We will also examine whether ADHD in this population is associated with functional and familial correlates associated with ADHD.

Registry
clinicaltrials.gov
Start Date
October 2008
End Date
February 2010
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Craig B. Surman, MD

Scientific Coordinator of the Adult ADHD Program, Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Male and female outpatients between, and including, 18 and 55 years of age with a history of eating disorder diagnosis.

Exclusion Criteria

  • Any clinically unstable psychiatric conditions such as: acute psychosis, acute panic, acute obsessive compulsive disorder, acute mania, acute suicidality, acute substance use disorders (alcohol or drugs), and sociopathy.
  • Any metabolic, neurological, hepatic, renal, cardiovascular, hematological, opthalmic, or endocrine disease that would confound ability to participate in valid assessments.
  • Mental retardation (IQ \<75).
  • Organic brain disorders.
  • Non-English speaking subjects will not be allowed into the study because the assessment instruments are unavailable and have not been adequately standardized in other languages.

Outcomes

Primary Outcomes

We will identify the lifetime rate of mental health conditions using structured clinical interviews in subjects with a lifetime history of eating disorders and compare the rate of these conditions to that of non-ED control subjects.

Time Frame: 1 time

Similar Trials